Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease
Background & Aims Around 10–20% of patients with non-alcoholic fatty liver disease
(NAFLD) are non-obese. The benefit of weight reduction in such patients is unclear. We aim …
(NAFLD) are non-obese. The benefit of weight reduction in such patients is unclear. We aim …
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
NAFLD is a spectrum of progressive liver disease that encompasses simple steatosis,
NASH, fibrosis and, ultimately, cirrhosis. NAFLD is recognized as the hepatic component of …
NASH, fibrosis and, ultimately, cirrhosis. NAFLD is recognized as the hepatic component of …
Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis
BK Koo, D Kim, SK Joo, JH Kim, MS Chang, BG Kim… - Journal of …, 2017 - Elsevier
Background & Aims We explored whether sarcopenia is associated with the histological
severity of non-alcoholic fatty liver disease (NAFLD), especially non-alcoholic steatohepatitis …
severity of non-alcoholic fatty liver disease (NAFLD), especially non-alcoholic steatohepatitis …
[HTML][HTML] Lifestyle modification in NAFLD/NASH: facts and figures
K Hallsworth, LA Adams - JHEP Reports, 2019 - Elsevier
The development of non-alcoholic fatty liver disease is closely linked to lifestyle factors,
namely excessive caloric intake coupled with reduced physical activity and exercise. This …
namely excessive caloric intake coupled with reduced physical activity and exercise. This …
Nonalcoholic fatty liver disease in adults: current concepts in etiology, outcomes, and management
T Marjot, A Moolla, JF Cobbold, L Hodson… - Endocrine …, 2020 - academic.oup.com
Nonalcoholic fatty liver disease (NAFLD) is a spectrum of disease, extending from simple
steatosis to inflammation and fibrosis with a significant risk for the development of cirrhosis. It …
steatosis to inflammation and fibrosis with a significant risk for the development of cirrhosis. It …
[HTML][HTML] KASL clinical practice guidelines: management of nonalcoholic fatty liver disease
The prevalence of nonalcoholic fatty liver disease (NAFLD) is increasing rapidly worldwide
as the obese and diabetic populations increase, and it has been estimated to be 20–30% in …
as the obese and diabetic populations increase, and it has been estimated to be 20–30% in …
Lifestyle changes in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis
T Fernández, M Viñuela, C Vidal, F Barrera - PloS one, 2022 - journals.plos.org
Background Non-alcoholic fatty liver disease is a liver condition that is increasing worldwide
and expected to become the number one cause of cirrhosis and hepatocellular carcinoma in …
and expected to become the number one cause of cirrhosis and hepatocellular carcinoma in …
AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions
This review summarizes our current understanding of nonalcoholic fatty liver disease
(NAFLD), a multi-factorial systemic disease resulting from a complex interaction between a …
(NAFLD), a multi-factorial systemic disease resulting from a complex interaction between a …
Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta …
G Musso, M Cassader, F Rosina, R Gambino - Diabetologia, 2012 - Springer
Aims/hypothesis Non-alcoholic fatty liver disease (NAFLD) encompasses a spectrum
ranging from simple steatosis to non-alcoholic steatohepatitis (NASH): NAFLD causes an …
ranging from simple steatosis to non-alcoholic steatohepatitis (NASH): NAFLD causes an …